Brazil
Canada
Germany
Japan
Our commitment to improving lives goes well beyond our medicines.
Please note that Horizon’s patient support program is for eligible U.S. residents only.
Managing a condition and treatment can involve a lot of moving parts. Horizon By Your Side is a patient support program with dedicated team members who take a personalized approach to meeting the unique needs of patients prescribed Horizon medicines.
The Horizon By Your Side team will work with each patient so they can focus on the future they deserve.
Connect
Coordinate
Champion
If you have been prescribed ACTIMMUNE and are interested in the Horizon By Your Side program, you can call 1-877-305-7704 or visit the website for additional details including Full Prescribing Information.
If you have been prescribed BUPHENYL and are interested in the Horizon By Your Side program, you can call 1-855-823-7878 or visit the website for additional details including Full Prescribing Information.
If you have been prescribed KRYSTEXXA and are interested in the Horizon By Your Side program, you can call 1-877-633-9521 or visit the website for additional details including Full Prescribing Information and Boxed Warning.
If you have been prescribed PROCYSBI and are interested in the Horizon By Your Side program, you can call 1-855-888-4004 or visit the website for additional details including Full Prescribing Information.
If you have been prescribed RAVICTI and are interested in the Horizon By Your Side program, you can call 1-855-823-7878 or visit the website for additional details including Full Prescribing Information.
If you have been prescribed TEPEZZA and are interested in the Horizon By Your Side program, you can call 1-833-583-7399 or visit the website for additional details including Full Prescribing Information.
If you have been prescribed UPLIZNA and are interested in the Horizon By Your Side program, you can call 1-833-842-8477 or visit the website for additional details including Full Prescribing Information.
We offer support and assistance so that eligible patients are able to receive our medicines regardless of their ability to pay. Through our various programs, we've provided more than $1 billion in patient support every year since 2015.
C-HZN-US-00205